Literature DB >> 2801305

Effect of interleukin-1-beta and tumor necrosis factor-alpha on cartilage proteoglycan metabolism in vitro.

M A Pratta1, T M Di Meo, D M Ruhl, E C Arner.   

Abstract

The activities of recombinant interleukin-1-beta (IL-1) and recombinant tumor necrosis factor-alpha (TNF) on cartilage proteoglycan metabolism were compared in an organ culture system. IL-1, 1 to 100 ng/ml, and TNF, 10 to 1,000 ng/ml, increased proteoglycan degradation. The concentration-response curves were parallel. The timecourse for degradation was similar for the two cytokines during a 6 day incubation. Both cytokines inhibited the synthesis of new proteoglycan as measured by 35S incorporation. The inhibition curves were parallel and concentration-related between 1 and 10 ng/ml for IL-1 and between 10 and 100 ng/ml for TNF. Maximal inhibition was 60% in the presence of IL-1 (10 ng/ml) or TNF (100 ng/ml), and plateaued at higher concentrations. IL-1 was ten fold more potent than TNF in stimulating proteoglycan breakdown and inhibiting proteoglycan synthesis. Degradation in response to TNF, but not to IL-1, could be blocked by a polyclonal antibody to TNF. A polyclonal antibody to IL-1 could block proteoglycan breakdown in response to both cytokines suggesting that TNF may be mediating proteoglycan degradation by inducing the production of interleukin-1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2801305     DOI: 10.1007/bf01972788

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

Review 1.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

2.  High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta.

Authors:  J J Huang; R C Newton; K Pezzella; M Covington; T Tamblyn; S J Rutlege; J Gray; M Kelley; Y Lin
Journal:  Mol Biol Med       Date:  1987-06

3.  Synthesis of interleukin-1-like activity by normal rat chondrocytes in culture.

Authors:  N C Rath; A L Oronsky; S S Kerwar
Journal:  Clin Immunol Immunopathol       Date:  1988-04

4.  Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation.

Authors:  E C Arner; L R Darnell; M A Pratta; R C Newton; N R Ackerman; W Galbraith
Journal:  Agents Actions       Date:  1987-08

5.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Authors:  P P Nawroth; I Bank; D Handley; J Cassimeris; L Chess; D Stern
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

6.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

7.  Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage.

Authors:  J Saklatvala
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

  7 in total
  12 in total

1.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines.

Authors:  G A Homandberg; F Hui; C Wen; C Purple; K Bewsey; H Koepp; K Huch; A Harris
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Coculture of human articular chondrocytes with peripheral blood mononuclear cells as a model to study cytokine-mediated interactions between inflammatory cells and target cells in the rheumatoid joint.

Authors:  A M Malfait; G Verbruggen; K F Almqvist; C Broddelez; E M Veys
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

4.  Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography.

Authors:  A Müller; G Hein; S Franke; D Herrmann; S Henzgen; A Roth; G Stein
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

5.  Emerging ideas: prevention of posttraumatic arthritis through interleukin-1 and tumor necrosis factor-alpha inhibition.

Authors:  J Todd R Lawrence; James Birmingham; Alison P Toth
Journal:  Clin Orthop Relat Res       Date:  2010-12-16       Impact factor: 4.176

Review 6.  The role of the cartilage matrix in osteoarthritis.

Authors:  Dick Heinegård; Tore Saxne
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

7.  Short-term exposure of cartilage to blood results in chondrocyte apoptosis.

Authors:  Michel Hooiveld; Goris Roosendaal; Marion Wenting; Marijke van den Berg; Johannes Bijlsma; Floris Lafeber
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

8.  A stable isotope method for the simultaneous measurement of matrix synthesis and cell proliferation in articular cartilage in vivo.

Authors:  K W Li; S A Siraj; E W Cheng; M Awada; M K Hellerstein; S M Turner
Journal:  Osteoarthritis Cartilage       Date:  2009-02-07       Impact factor: 6.576

9.  Synovial fluid cytokine concentrations as possible prognostic indicators in the ACL-deficient knee.

Authors:  M L Cameron; F H Fu; H H Paessler; M Schneider; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1994       Impact factor: 4.342

10.  Cell-penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants.

Authors:  Rush L Bartlett; Shaili Sharma; Alyssa Panitch
Journal:  Nanomedicine       Date:  2012-10-03       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.